Secondary biogenic amine deficiencies: genetic etiology, therapeutic interventions, and clinical effects-Reference-Cited by-同舟云学术

Secondary biogenic amine deficiencies: genetic etiology, therapeutic interventions, and clinical effects

Published:2021-07-02 Issue:4 Volume:22 Page:251-262
ISSN:1364-6745
Container-title:neurogenetics
language:en
Short-container-title:Neurogenetics

Author:

van Karnebeek Clara D.,Blydt-Hansen Ingrid,Matthews Allison M.,Avramovic Vladimir,Price Magda,Drogemoller Britt,Shyr Casper,Lee Jessica,Mwenifumbo Jill,Ghani Aisha,Stockler Sylvia,Friedman Jan M.,Lehman Anna,Ross Colin J.,Wasserman Wyeth W.,Tarailo-Graovac Maja^ORCID,Horvath Gabriella A.,

Funder

BC Children’s Hospital Foundation

Genome BC

Rare Diseases Foundation

Canadian Institutes of Health Research

Michael Smith Foundation for Health Research

Genome Canada

CIHR New Investigator Award

CFRI Fellowship to AM

Alberta Children’s Hospital Research Institute Foundation Díaz

Publisher

Springer Science and Business Media LLC

Subject

Cellular and Molecular Neuroscience,Genetics (clinical),Genetics

Link

https://link.springer.com/content/pdf/10.1007/s10048-021-00652-7.pdf

Reference36 articles.

1. Purves D, Augustine GJ, Fitzpatrick D, et al (2001) Neuroscience. 2nd edition. Sunderland (MA): Sinauer Associates; 2001. Available from: https://www.ncbi.nlm.nih.gov/books/NBK10799/

2. Ng J, Papandreou A, Heales SJ, Kurian MA (2015) Monoamine neurotransmitter disorders - clinical advances and future perspectives. Nat Rev Neurol. https://doi.org/10.1038/nrneurol.2015.172

3. Mercimek-Mahmutoglu S, Sidky S, Hyland K, Patel J, Donner J, Logan W, Mendoza-Londono R, et al (2015) Prevalence of inherited neurotransmitter disorders in patients with movement disorders and epilepsy: a retrospective cohort study. Orphanet Rare Dis 10(1). https://doi.org/10.1186/s13023-015-0234-9

4. De Grandis E, Serrano M, Pérez-Dueñas B, Ormazábal A, Montero R, Veneselli E, Pineda M et al (2010) Cerebrospinal fluid alterations of the serotonin product, 5-hydroxyindolacetic acid, in neurological disorders. J Inherit Metab Dis 33(6):803–809. https://doi.org/10.1007/s10545-010-9200-9

5. Molero-Luis M, Serrano M, Ormazábal A, Pérez-Dueñas B, García-Cazorla À, Pons R, Artuch R (2013) Homovanillic acid in cerebrospinal fluid of 1388 children with neurological disorders. Dev Med Child Neurol 55(6):559–566. https://doi.org/10.1111/dmcn.12116

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical Characteristics Suggestive of a Genetic Cause in Cerebral Palsy: A Systematic Review;Pediatric Neurology;2024-04

2. Assessment and quantification of homovanillic acid and vanillylmandelic acid in rodent urine samples using a validated high-performance liquid chromatography-ultraviolet method;Asian Journal of Pharmaceutical Research and Health Care;2022